Liberty Energy Inc. (LBRT)
NYSE: LBRT · Real-Time Price · USD
11.02
-0.38 (-3.33%)
At close: Aug 7, 2025, 4:00 PM
11.00
-0.02 (-0.20%)
After-hours: Aug 7, 2025, 7:59 PM EDT
Sage Therapeutics Stock Forecast
Stock Price Forecast
The 9 analysts that cover Sage Therapeutics stock have a consensus rating of "Buy" and an average price target of $15.61, which forecasts a 41.65% increase in the stock price over the next year. The lowest target is $12 and the highest is $20.
Price Target: $15.61 (+41.65%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Sage Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 4 | 4 | 3 | 3 | 3 | 2 |
| Hold | 4 | 4 | 6 | 7 | 7 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 10 | 11 | 11 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $16 → $14 | Buy | Maintains | $16 → $14 | +27.04% | Jul 29, 2025 |
| Stifel | Stifel | Strong Buy Maintains $20 → $19 | Strong Buy | Maintains | $20 → $19 | +72.41% | Jul 28, 2025 |
| Piper Sandler | Piper Sandler | Hold Initiates $14 | Hold | Initiates | $14 | +27.04% | Jul 15, 2025 |
| Wells Fargo | Wells Fargo | Hold Maintains $11 → $12 | Hold | Maintains | $11 → $12 | +8.89% | Jun 5, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $16 → $13 | Hold | Maintains | $16 → $13 | +17.97% | May 28, 2025 |
Financial Forecast
Revenue This Year
3.95B
from 4.32B
Decreased by -8.51%
Revenue Next Year
3.98B
from 3.95B
Increased by 0.91%
EPS This Year
0.41
from 1.87
Decreased by -78.30%
EPS Next Year
0.49
from 0.41
Increased by 21.79%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.2B | 4.6B | 4.7B | ||
| Avg | 3.9B | 4.0B | 4.2B | ||
| Low | 3.7B | 3.5B | 3.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -3.3% | 17.4% | 16.7% | ||
| Avg | -8.5% | 0.9% | 4.5% | ||
| Low | -15.0% | -10.7% | -6.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.61 | 1.59 | 1.93 | ||
| Avg | 0.41 | 0.49 | 1.13 | ||
| Low | 0.15 | 0.03 | 0.40 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -67.4% | 290.8% | 291.0% | ||
| Avg | -78.3% | 21.8% | 129.1% | ||
| Low | -92.1% | -91.5% | -18.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.